Plasma Therapy Market
Global Plasma Therapy Market Size, Share & Trends Analysis Report by Type (Leukocyte-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (PRF), Leucocyte-Rich PRP, and Pure PRP), by Application (Orthopedics, Dermatology, Dental, and Others), and by End-User (Hospitals & Clinics and Research Institutions) Forecast Period (2022-2028)
The global plasma therapy market is anticipated to grow at a significant CAGR of 13.1% during the forecast period. The factors driving the plasma therapy market are the rising prevalence of life-threatening diseases which includes various neurological system disorders such as chronic inflammatory demyelinating polyneuropathy (CIPD), idiopathic thrombocytopenic purpura (ITP), multifocal motor neuropathy (MMN). In addition, the rise in the occurrence of contagious diseases such as hepatitis A&B, tetanus, and rabies is estimated to impact the market positively during the forecast period.
An impressive technological advancement over the period has added much more to the therapies for the treatment of various diseases which has also led to the introduction of cost-effective protein fractioning technologies from plasma. This is also being seen as a major booster to the growth of the plasma therapy market during the forecast period. As per estimates by the World Health Organization (WHO) about 108 million global blood donations come from high-income countries, which is the home to 18% of the world’s population. The presence of a favorable government initiates the development of plasma-derived medicine and raising awareness regarding the importance of blood donation are the key drivers for this market.
Impact of COVID-19 Pandemic on Global Plasma Therapy Market
Due to a scarcity of antiviral treatments and the fact that plasma therapy is considered an emergency treatment approach, the present COVID-19 pandemic has helped to boost the market. Platelet-rich plasma can be utilized for pain management during COVID-19, which is one of its advantages. This approach, which has been used to prevent surgery, is also helpful in giving short-term pain relief in patients who are awaiting surgical clearance and do not want to be delayed any further by the side effects of steroids.
Segmental Outlook
The global plasma therapy market is segmented based on type, application, and end-user. Based on type, the plasma therapy market is segmented into leukocyte-rich fibrin (L-PRF), pure platelet-rich fibrin (PRF), leucocyte-rich PRP, and pure PRP. The pure PRP segment is estimated to account for the largest share of the global market during the forecast period. One of the most significant factors driving the growth of this market includes the effective results of pure PRP therapy. However, the lack of reimbursement policies and varying prices of plasma therapy are hindering the growth of the market. Based on application, the plasma therapy market is segmented into orthopedics, dermatology, dental, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. Based on end-user, the market is classified into hospitals & clinics, and research institutions. The hospitals & clinics segment is estimated to account for the largest share of the global market during the forecast period.
Global Plasma Therapy Market Share by Application, 2021 (%)
The Orthopaedics Segment is Expected to Hold a Prominent Share in the Global Plasma Therapy Market
The orthopedics segment is anticipated to hold a significant share in the market owing to the increase in the incidence rate of orthopedic diseases. According to the World Health Organization (WHO), symptomatic osteoarthritis affects 9.6% of men and 18% of women over the age of 60 worldwide. 80% of them have movement restrictions, and 25% are unable to do daily tasks.
Regional Outlooks
The global plasma therapy market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The North American region is anticipated to be the fastest-growing region in the plasma therapy market owing to the growing number of hospitals and clinics which is increasing the demand for plasma therapy. The key driving forces expected to boost the market of plasma therapy in North America are rising awareness levels among blood donors, the presence of advanced protein fractioning procedures, and higher per capita income in developed countries.
Global Plasma Therapy Market Growth, by Region 2022-2028
The North American Region is Anticipated to hold the Prominent Share in the Global Plasma Therapy Market
The North American region is anticipated to hold a prominent share of the plasma therapy market owing to the rise in the prevalence of numerous diseases, such as arthritis, well-established healthcare infrastructure, improved regulatory environment, and government assistance. According to a poll done by the Centers for Disease Control and Prevention (CDC) in 2020, one out of every four persons in the US had arthritis, with a projected 78 million adults anticipated to suffer from the disease by 2040. Furthermore, the prevalence of doctor-diagnosed arthritis is predicted to climb dramatically in the region during the forecast period, owing to the region's aging population. Osteoarthritis is the most common kind of arthritis, affecting around 31 million Americans each year.
Market Players Outlook
The major companies serving the global plasma therapy market include Arthrex Inc., China Biologic Products Inc., and Johnson and Johnson. The companies are focusing on product innovations, expansions, mergers and acquisitions, and finding a new market or innovation in their core competency to expand individual market share. For instance, PRP (Platelet-rich Plasma) Microneedling Facelifts for patients were introduced by Atlas Health Medical Group in February 2021.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global plasma therapy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1.Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Plasma Therapy Market
- Recovery Scenario of Global Plasma Therapy Market
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.By Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.Key Company Analysis
3.1.1.Overview
3.1.2.Financial Analysis
3.1.3.SWOT Analysis
3.1.4.Recent Developments
3.2.Key Strategy Analysis
3.3.Impact of COVID-19 on Key Players
4.Market Segmentation
4.1.Global Plasma Therapy Market by Type
4.1.1.Leukocyte-Rich Fibrin
4.1.2.Pure Platelet-Rich Fibrin
4.1.3.Leukocyte-Rich PRP
4.1.4.Pure PRP
4.2.Global Plasma Therapy Market by Application
4.2.1.Orthopedics
4.2.1.1.Arthritis
4.2.1.2.Chronic Tendinitis
4.2.1.3.Bone Repair & Regeneration
4.2.2.Dermatology
4.2.2.1.Androgenic Alopecia
4.2.2.2.Plastic Surgery
4.2.3.Dental
4.2.4.Others (Nerve Injury)
4.3.Global Plasma Therapy Market by End-User
4.3.1.Hospitals and Clinics
4.3.2.Research Institute
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Baxter International
6.2.Biolife Plasma Services
6.3.Biotest
6.4.Bio Product Laboratory Ltd. (BPL)
6.5.CSL LTD.
6.6.China Biologic Products, Inc.
6.7. Grifols International S.A.
6.8.Johnson and Johnson, Inc.
6.9. Kedrion S.P.A.
6.10. LFB SA
6.11.Octapharma Plasma
6.12.Ge Healthcare
6.13.Arthrex Inc
6.14.Regen Lab
6.15.Tri-Star Technologies
1.GLOBAL PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2.GLOBAL LEUKOCYTE-RICH FIBRIN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL PURE PLATELET-RICH FIBRIN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL LEUKOCYTE-RICH PRP PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5.GLOBAL PURE PRP PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7.GLOBAL PLASMA THERAPY IN ORTHOPAEDICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL PLASMA THERAPY IN DERMATOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9.GLOBAL PLASMA THERAPY IN DENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10.GLOBAL PLASMA THERAPY IN OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBAL BOTTLED PLASMA THERAPY IN HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBAL PLASMA THERAPY IN RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13.GLOBAL PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
14.NORTH AMERICAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15.NORTH AMERICAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
16.NORTH AMERICAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17.NORTH AMERICAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
18.EUROPEAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19.EUROPEAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20.EUROPEAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
21.EUROPEAN PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
22.ASIA-PACIFIC PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23.ASIA-PACIFIC PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
24.ASIA-PACIFIC PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
25.ASIA-PACIFIC PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
26.REST OF THE WORLD PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27.REST OF THE WORLD PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
28.REST OF THE WORLD PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
29.REST OF THE WORLD PLASMA THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL PLASMA THERAPY MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL PLASMA THERAPY MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL PLASMA THERAPY MARKET, 2022-2028 (%)
4.GLOBAL PLASMA THERAPY MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5.GLOBAL LEUKOCYTE-RICH FIBRIN PLASMA THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL PURE PLATELET-RICH FIBRIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL LEUKOCYTE-RICH PRP MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8.GLOBAL PURE PRP PLASMA THERAPY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL PLASMA THERAPY MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
10.GLOBAL PLASMA THERAPY FOR ORTHOPAEDICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL PLASMA THERAPY FOR DERMATOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12.GLOBAL PLASMA THERAPY FOR DENTAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13.GLOBAL PLASMA THERAPY FOR OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL PLASMA THERAPY MARKET SHARE BY END-USER, 2021 VS 2028 (%)
15.GLOBAL PLASMA THERAPY IN HOSPITALS AND CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16.GLOBAL PLASMA THERAPY IN RESEARCH INSTITUTE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17.US PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
18.CANADA PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
19.UK PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
20.FRANCE PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
21.GERMANY PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
22.ITALY PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
23.SPAIN PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
24.REST OF EUROPE PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
25.INDIA PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
26.CHINA PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
27.JAPAN PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
28.SOUTH KOREA PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
29.REST OF ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
30.REST OF THE WORLD PLASMA THERAPY MARKET SIZE, 2021-2028 ($ MILLION)
